Drug Research
Gene Therapy Transactions Give Wall Street Cautious Optimism
Gene therapy remains a topic of fascination to biopharmaceutical dealmakers despite safety worries and opposition from drug regulators, as seen by a recent flurry of deals.
Eli Lilly agreed to purchase Akouos, a Boston-based company that develops gene therapies for...
Drug Research
Robotic Capsules Are Here, Enhancing The Gut Drug Delivery
One of the most difficult medical research findings, drug distribution still faces a lot of challenges, including surviving the acidic parts of the stomach, digestive enzymes, and most significantly, the mucus barrier that surrounds the digestive canal. Scientists at...
News
Energy Crisis May Affect Europe Pharma Supplies, Trade Fears
Rising energy prices in Europe run the risk of accelerating the migration of businesses necessary for the production of life-saving medications, further jeopardising the pharma supply chains that were already struggling under the worst of COVID-19.
Essential medications are important...
News
Analysis of Third-Party Logistics Services In The Biopharma Industry
In 2021, the market for third-party logistics for the biopharmaceutical industry was estimated to be worth USD 117.25 billion. By 2030, it is expected to have grown to USD 195.75 billion, with a CAGR of 5.86% from 2022 to...
News
How to Spend Wisely When Buying Dietary Supplements
Your health comes first. Consequently, you don't mind spending more to buy all the supplements your doctor recommended. But you might face a financial crisis soon if you're not careful about the amount you've allocated to supplements.
It's even worse...
News
5 Tech Companies Shaping The Future Of Healthcare
The healthcare industry is undergoing a massive transformation. According to Statista, it's an industry that grew at a rate of 15.9% within five years from 2016, projected to reach USD$59.70 billion in 2022. Sure, the influence of technology is...
Drug Research
Biopharma Mergers and Acquisitions on a Rise
Deals can be just as significant in the drug development industry as scientific advancements. Without mergers and acquisitions, many of today's most significant pharmaceuticals—from the anti-inflammatory Humira to the life-saving cancer medication Keytruda—might not have come to be.
Pharmaceutical M&A...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read